These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 27914703

  • 1. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS, International IgA Nephropathy Working Group.
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [Abstract] [Full Text] [Related]

  • 2. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS, Troyanov S, Vorobyeva O, Coppo R, Roberts ISD, Validation in IgA Nephropathy study group.
    Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
    [Abstract] [Full Text] [Related]

  • 3. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
    El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D.
    Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
    [Abstract] [Full Text] [Related]

  • 4. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
    Trimarchi H, Coppo R.
    Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
    [Abstract] [Full Text] [Related]

  • 5. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyHospital Británico de Buenos Aires, Argentina., Conference Participants.
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F.
    Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
    [Abstract] [Full Text] [Related]

  • 7. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
    Cook HT.
    Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
    [Abstract] [Full Text] [Related]

  • 8. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR, Vieira MR, Pereira LHM, Araújo LS, Silva CA, Araújo LB, Rocha LP, Reis MAD, Machado JR.
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [Abstract] [Full Text] [Related]

  • 9. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC.
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [Abstract] [Full Text] [Related]

  • 10. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 11. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [Abstract] [Full Text] [Related]

  • 12. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
    Hill GS, Karoui KE, Karras A, Mandet C, Van Huyen JD, Nochy D, Bruneval P.
    Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
    [Abstract] [Full Text] [Related]

  • 13. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL, Rose CL, Magil AB.
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [Abstract] [Full Text] [Related]

  • 14. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.
    Haas M.
    Am J Kidney Dis; 1996 Sep; 28(3):365-71. PubMed ID: 8804234
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A, MacEwen C, Bellur SS, Chompuk LO, Lunn D, Roberts ISD.
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [Abstract] [Full Text] [Related]

  • 16. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
    Haas M.
    Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401
    [Abstract] [Full Text] [Related]

  • 17. Clinical and histological differences between adults and children in new onset IgA nephropathy.
    Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
    [Abstract] [Full Text] [Related]

  • 18. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM.
    Rev Assoc Med Bras (1992); 2024 Oct; 70(4):e20230871. PubMed ID: 38716932
    [Abstract] [Full Text] [Related]

  • 19. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
    Stokes MB, Valeri AM, Markowitz GS, D'Agati VD.
    Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
    [Abstract] [Full Text] [Related]

  • 20. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
    Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM, CureGN Consortium.
    Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.